FrCas9 is a CRISPR/Cas9 system with high editing efficiency and fidelity

Genome editing technologies hold tremendous potential in biomedical research and drug development. Therefore, it is imperative to discover gene editing tools with superior cutting efficiency, good fidelity, and fewer genomic restrictions. Here, we report a CRISPR/Cas9 from Faecalibaculum rodentium ,...

Full description

Saved in:
Bibliographic Details
Published inNature communications Vol. 13; no. 1; pp. 1425 - 12
Main Authors Cui, Zifeng, Tian, Rui, Huang, Zhaoyue, Jin, Zhuang, Li, Lifang, Liu, Jiashuo, Huang, Zheying, Xie, Hongxian, Liu, Dan, Mo, Haiyan, Zhou, Rong, Lang, Bin, Meng, Bo, Weng, Haiyan, Hu, Zheng
Format Journal Article
LanguageEnglish
Published London Nature Publishing Group UK 17.03.2022
Nature Publishing Group
Nature Portfolio
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Genome editing technologies hold tremendous potential in biomedical research and drug development. Therefore, it is imperative to discover gene editing tools with superior cutting efficiency, good fidelity, and fewer genomic restrictions. Here, we report a CRISPR/Cas9 from Faecalibaculum rodentium , which is characterized by a simple PAM (5′-NNTA-3′) and a guide RNA length of 21–22 bp. We find that FrCas9 could achieve comparable efficiency and specificity to SpCas9. Interestingly, the PAM of FrCas9 presents a palindromic sequence, which greatly expands its targeting scope. Due to the PAM sequence, FrCas9 possesses double editing-windows for base editor and could directly target the TATA-box in eukaryotic promoters for TATA-box related diseases. Together, our results broaden the understanding of CRISPR/Cas-mediated genome engineering and establish FrCas9 as a safe and efficient platform for wide applications in research, biotechnology and therapeutics. Gene editing tools have tremendous potential for biomedical and basic research. Here the authors report a Cas9 from Faecalibaculum rodentium (FrCas9) that achieves efficient and specific gene editing in human cells with a NNTA palindrome PAMs for targeting optimal sites at TATA-boxes to enhance CRISPRa/i screening.
AbstractList Genome editing technologies hold tremendous potential in biomedical research and drug development. Therefore, it is imperative to discover gene editing tools with superior cutting efficiency, good fidelity, and fewer genomic restrictions. Here, we report a CRISPR/Cas9 from Faecalibaculum rodentium, which is characterized by a simple PAM (5'-NNTA-3') and a guide RNA length of 21-22 bp. We find that FrCas9 could achieve comparable efficiency and specificity to SpCas9. Interestingly, the PAM of FrCas9 presents a palindromic sequence, which greatly expands its targeting scope. Due to the PAM sequence, FrCas9 possesses double editing-windows for base editor and could directly target the TATA-box in eukaryotic promoters for TATA-box related diseases. Together, our results broaden the understanding of CRISPR/Cas-mediated genome engineering and establish FrCas9 as a safe and efficient platform for wide applications in research, biotechnology and therapeutics.
Genome editing technologies hold tremendous potential in biomedical research and drug development. Therefore, it is imperative to discover gene editing tools with superior cutting efficiency, good fidelity, and fewer genomic restrictions. Here, we report a CRISPR/Cas9 from Faecalibaculum rodentium, which is characterized by a simple PAM (5′-NNTA-3′) and a guide RNA length of 21–22 bp. We find that FrCas9 could achieve comparable efficiency and specificity to SpCas9. Interestingly, the PAM of FrCas9 presents a palindromic sequence, which greatly expands its targeting scope. Due to the PAM sequence, FrCas9 possesses double editing-windows for base editor and could directly target the TATA-box in eukaryotic promoters for TATA-box related diseases. Together, our results broaden the understanding of CRISPR/Cas-mediated genome engineering and establish FrCas9 as a safe and efficient platform for wide applications in research, biotechnology and therapeutics.Gene editing tools have tremendous potential for biomedical and basic research. Here the authors report a Cas9 from Faecalibaculum rodentium (FrCas9) that achieves efficient and specific gene editing in human cells with a NNTA palindrome PAMs for targeting optimal sites at TATA-boxes to enhance CRISPRa/i screening.
Genome editing technologies hold tremendous potential in biomedical research and drug development. Therefore, it is imperative to discover gene editing tools with superior cutting efficiency, good fidelity, and fewer genomic restrictions. Here, we report a CRISPR/Cas9 from Faecalibaculum rodentium , which is characterized by a simple PAM (5′-NNTA-3′) and a guide RNA length of 21–22 bp. We find that FrCas9 could achieve comparable efficiency and specificity to SpCas9. Interestingly, the PAM of FrCas9 presents a palindromic sequence, which greatly expands its targeting scope. Due to the PAM sequence, FrCas9 possesses double editing-windows for base editor and could directly target the TATA-box in eukaryotic promoters for TATA-box related diseases. Together, our results broaden the understanding of CRISPR/Cas-mediated genome engineering and establish FrCas9 as a safe and efficient platform for wide applications in research, biotechnology and therapeutics. Gene editing tools have tremendous potential for biomedical and basic research. Here the authors report a Cas9 from Faecalibaculum rodentium (FrCas9) that achieves efficient and specific gene editing in human cells with a NNTA palindrome PAMs for targeting optimal sites at TATA-boxes to enhance CRISPRa/i screening.
Genome editing technologies hold tremendous potential in biomedical research and drug development. Therefore, it is imperative to discover gene editing tools with superior cutting efficiency, good fidelity, and fewer genomic restrictions. Here, we report a CRISPR/Cas9 from Faecalibaculum rodentium , which is characterized by a simple PAM (5′-NNTA-3′) and a guide RNA length of 21–22 bp. We find that FrCas9 could achieve comparable efficiency and specificity to SpCas9. Interestingly, the PAM of FrCas9 presents a palindromic sequence, which greatly expands its targeting scope. Due to the PAM sequence, FrCas9 possesses double editing-windows for base editor and could directly target the TATA-box in eukaryotic promoters for TATA-box related diseases. Together, our results broaden the understanding of CRISPR/Cas-mediated genome engineering and establish FrCas9 as a safe and efficient platform for wide applications in research, biotechnology and therapeutics.
Gene editing tools have tremendous potential for biomedical and basic research. Here the authors report a Cas9 from Faecalibaculum rodentium (FrCas9) that achieves efficient and specific gene editing in human cells with a NNTA palindrome PAMs for targeting optimal sites at TATA-boxes to enhance CRISPRa/i screening.
Genome editing technologies hold tremendous potential in biomedical research and drug development. Therefore, it is imperative to discover gene editing tools with superior cutting efficiency, good fidelity, and fewer genomic restrictions. Here, we report a CRISPR/Cas9 from Faecalibaculum rodentium, which is characterized by a simple PAM (5'-NNTA-3') and a guide RNA length of 21-22 bp. We find that FrCas9 could achieve comparable efficiency and specificity to SpCas9. Interestingly, the PAM of FrCas9 presents a palindromic sequence, which greatly expands its targeting scope. Due to the PAM sequence, FrCas9 possesses double editing-windows for base editor and could directly target the TATA-box in eukaryotic promoters for TATA-box related diseases. Together, our results broaden the understanding of CRISPR/Cas-mediated genome engineering and establish FrCas9 as a safe and efficient platform for wide applications in research, biotechnology and therapeutics.Genome editing technologies hold tremendous potential in biomedical research and drug development. Therefore, it is imperative to discover gene editing tools with superior cutting efficiency, good fidelity, and fewer genomic restrictions. Here, we report a CRISPR/Cas9 from Faecalibaculum rodentium, which is characterized by a simple PAM (5'-NNTA-3') and a guide RNA length of 21-22 bp. We find that FrCas9 could achieve comparable efficiency and specificity to SpCas9. Interestingly, the PAM of FrCas9 presents a palindromic sequence, which greatly expands its targeting scope. Due to the PAM sequence, FrCas9 possesses double editing-windows for base editor and could directly target the TATA-box in eukaryotic promoters for TATA-box related diseases. Together, our results broaden the understanding of CRISPR/Cas-mediated genome engineering and establish FrCas9 as a safe and efficient platform for wide applications in research, biotechnology and therapeutics.
ArticleNumber 1425
Author Li, Lifang
Weng, Haiyan
Huang, Zheying
Zhou, Rong
Xie, Hongxian
Lang, Bin
Huang, Zhaoyue
Tian, Rui
Liu, Jiashuo
Liu, Dan
Mo, Haiyan
Cui, Zifeng
Jin, Zhuang
Hu, Zheng
Meng, Bo
Author_xml – sequence: 1
  givenname: Zifeng
  surname: Cui
  fullname: Cui, Zifeng
  organization: Department of Gynecological oncology, the First Affiliated Hospital, Sun Yat-sen University
– sequence: 2
  givenname: Rui
  surname: Tian
  fullname: Tian, Rui
  organization: Center for Translational Medicine, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Sun Yat-sen University Nanchang Research Institution
– sequence: 3
  givenname: Zhaoyue
  surname: Huang
  fullname: Huang, Zhaoyue
  organization: Department of Gynecological oncology, the First Affiliated Hospital, Sun Yat-sen University
– sequence: 4
  givenname: Zhuang
  surname: Jin
  fullname: Jin, Zhuang
  organization: Department of Gynecological oncology, the First Affiliated Hospital, Sun Yat-sen University
– sequence: 5
  givenname: Lifang
  surname: Li
  fullname: Li, Lifang
  organization: Department of Gynecological oncology, the First Affiliated Hospital, Sun Yat-sen University
– sequence: 6
  givenname: Jiashuo
  surname: Liu
  fullname: Liu, Jiashuo
  organization: Department of Gynecological oncology, the First Affiliated Hospital, Sun Yat-sen University
– sequence: 7
  givenname: Zheying
  surname: Huang
  fullname: Huang, Zheying
  organization: Department of Gynecological oncology, the First Affiliated Hospital, Sun Yat-sen University
– sequence: 8
  givenname: Hongxian
  surname: Xie
  fullname: Xie, Hongxian
  organization: Generulor Company Bio-X Lab
– sequence: 9
  givenname: Dan
  surname: Liu
  fullname: Liu, Dan
  organization: Generulor Company Bio-X Lab
– sequence: 10
  givenname: Haiyan
  surname: Mo
  fullname: Mo, Haiyan
  organization: Generulor Company Bio-X Lab
– sequence: 11
  givenname: Rong
  surname: Zhou
  fullname: Zhou, Rong
  organization: Generulor Company Bio-X Lab
– sequence: 12
  givenname: Bin
  surname: Lang
  fullname: Lang, Bin
  organization: School of Health Sciences and Sports, Macao Polytechnic Institute
– sequence: 13
  givenname: Bo
  surname: Meng
  fullname: Meng, Bo
  organization: Department of Pathology, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China
– sequence: 14
  givenname: Haiyan
  surname: Weng
  fullname: Weng, Haiyan
  email: whaiyan1166@163.com
  organization: Department of Pathology, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China
– sequence: 15
  givenname: Zheng
  orcidid: 0000-0001-9306-9442
  surname: Hu
  fullname: Hu, Zheng
  email: huzheng1998@163.com
  organization: Department of Gynecological oncology, the First Affiliated Hospital, Sun Yat-sen University, Sun Yat-sen University Nanchang Research Institution
BackLink https://www.ncbi.nlm.nih.gov/pubmed/35301321$$D View this record in MEDLINE/PubMed
BookMark eNp9Uk1vEzEUtFARLaV_gANaiQuXpf5c2xckFFEaqRKowNny-mPjaOMttlOUf4-TLaXtob746Xlm3tie1-AoTtEB8BbBjwgScZ4poh1vIcYtllDIVrwAJxhS1CKOydGD-hic5byGdRGJBKWvwDFhBCKC0Qm4vEgLnWUTcqObxfXyx_fr80Mj73Jxm-ZPKKtmFYZV42woIQ6N8z6Y4KLZNTraxgfrxlB2b8BLr8fszu72U_Dr4svPxWV79e3rcvH5qjWMwtISQazr6nDaEyYs51QzaQ3ve-m8cL1kfQeJ1kZ7BH0vOuEZs1I4yGXXU05OwXLWtZNeq5sUNjrt1KSDOjSmNCidSjCjU0yTXtjOUC487ZgX2CDLKDWmVg6bqvVp1rrZ9htnjYsl6fGR6OOTGFZqmG6VkAQhKqrAhzuBNP3eulzUJmTjxlFHN22zwh2FUhLKYYW-fwJdT9sU61MdUEzijrOKevfQ0b2Vfx9WAXgGmDTlnJy_hyCo9sFQczBUDYY6BEPtbYonJBOKLmHa3yqMz1PJTM11Thxc-m_7GdZfESXKhA
CitedBy_id crossref_primary_10_3390_pharmaceutics16020213
crossref_primary_10_59786_bmtj_221
crossref_primary_10_3390_ijms242216077
crossref_primary_10_1016_j_bcab_2025_103553
crossref_primary_10_1016_j_tim_2024_05_004
crossref_primary_10_1186_s43556_023_00115_5
crossref_primary_10_1007_s42994_024_00157_5
crossref_primary_10_1016_j_biotechadv_2025_108557
crossref_primary_10_1016_j_crmeth_2023_100444
crossref_primary_10_1094_MPMI_05_23_0072_SC
crossref_primary_10_1038_s42003_022_04258_z
crossref_primary_10_1021_acssynbio_3c00698
crossref_primary_10_1080_15476286_2023_2256578
crossref_primary_10_1038_s41580_025_00834_3
crossref_primary_10_1038_s42003_025_07893_4
crossref_primary_10_31857_S0026898423030163
crossref_primary_10_3390_ijms25010607
crossref_primary_10_1111_pbi_14363
crossref_primary_10_1016_j_medj_2023_05_005
crossref_primary_10_3390_ijms23158684
crossref_primary_10_1186_s12967_024_05570_4
crossref_primary_10_3390_cells11142186
crossref_primary_10_1021_acssynbio_3c00501
crossref_primary_10_1021_acssynbio_3c00141
crossref_primary_10_1134_S0026893323030147
crossref_primary_10_1016_j_celrep_2024_113765
crossref_primary_10_1038_s41467_025_56655_7
Cites_doi 10.1126/sciadv.aau0766
10.2302/kjm.2019-0009-OA
10.1038/nature16526
10.1126/science.aad5227
10.1038/nbt.2675
10.1126/science.1225829
10.1038/nmeth.2681
10.1093/nar/gki408
10.1186/s13059-019-1620-8
10.1016/j.cell.2015.09.038
10.1016/j.molcel.2016.12.023
10.1126/science.1231143
10.1038/s41467-017-01408-4
10.1073/pnas.1313587110
10.1038/nature24644
10.1093/nar/gkv1222
10.1093/nar/gky425
10.1093/nar/gkf436
10.1093/bioinformatics/bty560
10.1038/nbt.3437
10.1093/nar/gkaa998
10.1172/JCI78206
10.1038/s41596-020-00465-2
10.1093/bioinformatics/btu379
10.1016/j.cell.2014.05.010
10.1038/nbt.3117
10.1016/j.cell.2014.02.001
10.1002/humu.22535
10.1016/j.ebiom.2020.102897
10.1038/nbt.3534
10.1038/nature14592
10.1038/nmeth.1318
10.1186/s13059-020-01989-2
10.1038/s41467-020-19344-1
10.1126/sciadv.aao4774
10.1134/S0006297909020011
10.1093/molbev/msp077
10.1101/gr.162339.113
10.1038/nchembio.2559
10.1099/ijsem.0.001793
10.1371/journal.pone.0040913
10.1002/jcc.21596
10.1016/j.antiviral.2020.104794
10.1038/ncomms14500
10.1038/nature21059
10.1093/bioinformatics/btp324
10.7150/ijbs.24581
10.1038/nbt.2647
10.1093/bioinformatics/bts635
10.1038/nbt.2808
10.1093/bioinformatics/btr507
10.1093/database/baz093
10.1101/pdb.prot086785
ContentType Journal Article
Copyright The Author(s) 2022
2022. The Author(s).
The Author(s) 2022. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Copyright_xml – notice: The Author(s) 2022
– notice: 2022. The Author(s).
– notice: The Author(s) 2022. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
DBID C6C
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7QL
7QP
7QR
7SN
7SS
7ST
7T5
7T7
7TM
7TO
7X7
7XB
88E
8AO
8FD
8FE
8FG
8FH
8FI
8FJ
8FK
ABUWG
AEUYN
AFKRA
ARAPS
AZQEC
BBNVY
BENPR
BGLVJ
BHPHI
C1K
CCPQU
DWQXO
FR3
FYUFA
GHDGH
GNUQQ
H94
HCIFZ
K9.
LK8
M0S
M1P
M7P
P5Z
P62
P64
PHGZM
PHGZT
PIMPY
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQQKQ
PQUKI
PRINS
RC3
SOI
7X8
5PM
DOA
DOI 10.1038/s41467-022-29089-8
DatabaseName Springer Nature OA Free Journals
CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Bacteriology Abstracts (Microbiology B)
Calcium & Calcified Tissue Abstracts
Chemoreception Abstracts
Ecology Abstracts
Entomology Abstracts (Full archive)
Environment Abstracts
Immunology Abstracts
Industrial and Applied Microbiology Abstracts (Microbiology A)
Nucleic Acids Abstracts
Oncogenes and Growth Factors Abstracts
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
ProQuest Pharma Collection
Technology Research Database
ProQuest SciTech Collection
ProQuest Technology Collection
ProQuest Natural Science Collection
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest One Sustainability
ProQuest Central UK/Ireland
Advanced Technologies & Aerospace Collection
ProQuest Central Essentials
Biological Science Collection
ProQuest Central
ProQuest Technology Collection
Natural Science Collection
Environmental Sciences and Pollution Management
ProQuest One Community College
ProQuest Central Korea
Engineering Research Database
Proquest Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
AIDS and Cancer Research Abstracts
SciTech Premium Collection
ProQuest Health & Medical Complete (Alumni)
Biological Sciences
ProQuest Health & Medical Collection
Medical Database
Biological Science Database
Advanced Technologies & Aerospace Database
ProQuest Advanced Technologies & Aerospace Collection
Biotechnology and BioEngineering Abstracts
ProQuest Central Premium
ProQuest One Academic (New)
ProQuest Publicly Available Content Database
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Applied & Life Sciences
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
Genetics Abstracts
Environment Abstracts
MEDLINE - Academic
PubMed Central (Full Participant titles)
Directory of Open Access Journals
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Publicly Available Content Database
ProQuest Central Student
Oncogenes and Growth Factors Abstracts
ProQuest Advanced Technologies & Aerospace Collection
ProQuest Central Essentials
Nucleic Acids Abstracts
SciTech Premium Collection
ProQuest Central China
Environmental Sciences and Pollution Management
ProQuest One Applied & Life Sciences
ProQuest One Sustainability
Health Research Premium Collection
Natural Science Collection
Health & Medical Research Collection
Biological Science Collection
Chemoreception Abstracts
Industrial and Applied Microbiology Abstracts (Microbiology A)
ProQuest Central (New)
ProQuest Medical Library (Alumni)
Advanced Technologies & Aerospace Collection
ProQuest Biological Science Collection
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
ProQuest Technology Collection
Health Research Premium Collection (Alumni)
Biological Science Database
Ecology Abstracts
ProQuest Hospital Collection (Alumni)
Biotechnology and BioEngineering Abstracts
Entomology Abstracts
ProQuest Health & Medical Complete
ProQuest One Academic UKI Edition
Engineering Research Database
ProQuest One Academic
Calcium & Calcified Tissue Abstracts
ProQuest One Academic (New)
Technology Collection
Technology Research Database
ProQuest One Academic Middle East (New)
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Natural Science Collection
ProQuest Pharma Collection
ProQuest Central
ProQuest Health & Medical Research Collection
Genetics Abstracts
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
Bacteriology Abstracts (Microbiology B)
AIDS and Cancer Research Abstracts
ProQuest SciTech Collection
Advanced Technologies & Aerospace Database
ProQuest Medical Library
Immunology Abstracts
Environment Abstracts
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList MEDLINE
Publicly Available Content Database

CrossRef


MEDLINE - Academic
Database_xml – sequence: 1
  dbid: C6C
  name: Springer Nature OA Free Journals
  url: http://www.springeropen.com/
  sourceTypes: Publisher
– sequence: 2
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 3
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 4
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 5
  dbid: 8FG
  name: ProQuest Technology Collection
  url: https://search.proquest.com/technologycollection1
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Biology
EISSN 2041-1723
EndPage 12
ExternalDocumentID oai_doaj_org_article_5a3b8d6c478f465f82c1d544cc82ce2c
PMC8931148
35301321
10_1038_s41467_022_29089_8
Genre Research Support, Non-U.S. Gov't
Journal Article
GroupedDBID ---
0R~
39C
3V.
53G
5VS
70F
7X7
88E
8AO
8FE
8FG
8FH
8FI
8FJ
AAHBH
AAJSJ
ABUWG
ACGFO
ACGFS
ACIWK
ACMJI
ACPRK
ACSMW
ADBBV
ADFRT
ADMLS
ADRAZ
AENEX
AEUYN
AFKRA
AFRAH
AHMBA
AJTQC
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AMTXH
AOIJS
ARAPS
ASPBG
AVWKF
AZFZN
BBNVY
BCNDV
BENPR
BGLVJ
BHPHI
BPHCQ
BVXVI
C6C
CCPQU
DIK
EBLON
EBS
EE.
EMOBN
F5P
FEDTE
FYUFA
GROUPED_DOAJ
HCIFZ
HMCUK
HVGLF
HYE
HZ~
KQ8
LK8
M1P
M48
M7P
M~E
NAO
O9-
OK1
P2P
P62
PIMPY
PQQKQ
PROAC
PSQYO
RNS
RNT
RNTTT
RPM
SNYQT
SV3
TSG
UKHRP
AASML
AAYXX
CITATION
PHGZM
PHGZT
CGR
CUY
CVF
ECM
EIF
NPM
PJZUB
PPXIY
PQGLB
7QL
7QP
7QR
7SN
7SS
7ST
7T5
7T7
7TM
7TO
7XB
8FD
8FK
AARCD
AZQEC
C1K
DWQXO
FR3
GNUQQ
H94
K9.
P64
PKEHL
PQEST
PQUKI
PRINS
RC3
SOI
7X8
5PM
PUEGO
ID FETCH-LOGICAL-c540t-383de60134b358d774a59dc7bb9ef8eb95b603aacaf10fb868f55d98e0796b473
IEDL.DBID M48
ISSN 2041-1723
IngestDate Wed Aug 27 01:13:37 EDT 2025
Thu Aug 21 14:14:36 EDT 2025
Fri Jul 11 11:18:00 EDT 2025
Wed Aug 13 11:00:16 EDT 2025
Mon Jul 21 05:34:08 EDT 2025
Tue Jul 01 04:17:46 EDT 2025
Thu Apr 24 22:50:29 EDT 2025
Fri Feb 21 02:38:39 EST 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Language English
License 2022. The Author(s).
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c540t-383de60134b358d774a59dc7bb9ef8eb95b603aacaf10fb868f55d98e0796b473
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ORCID 0000-0001-9306-9442
OpenAccessLink http://journals.scholarsportal.info/openUrl.xqy?doi=10.1038/s41467-022-29089-8
PMID 35301321
PQID 2640592675
PQPubID 546298
PageCount 12
ParticipantIDs doaj_primary_oai_doaj_org_article_5a3b8d6c478f465f82c1d544cc82ce2c
pubmedcentral_primary_oai_pubmedcentral_nih_gov_8931148
proquest_miscellaneous_2640993470
proquest_journals_2640592675
pubmed_primary_35301321
crossref_primary_10_1038_s41467_022_29089_8
crossref_citationtrail_10_1038_s41467_022_29089_8
springer_journals_10_1038_s41467_022_29089_8
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2022-03-17
PublicationDateYYYYMMDD 2022-03-17
PublicationDate_xml – month: 03
  year: 2022
  text: 2022-03-17
  day: 17
PublicationDecade 2020
PublicationPlace London
PublicationPlace_xml – name: London
– name: England
PublicationTitle Nature communications
PublicationTitleAbbrev Nat Commun
PublicationTitleAlternate Nat Commun
PublicationYear 2022
Publisher Nature Publishing Group UK
Nature Publishing Group
Nature Portfolio
Publisher_xml – name: Nature Publishing Group UK
– name: Nature Publishing Group
– name: Nature Portfolio
References Gibson (CR45) 2009; 6
Kim (CR13) 2017; 8
CR34
Hsu (CR5) 2013; 31
Zadeh (CR36) 2011; 32
Zetsche, Abudayyeh, Gootenberg, Scott, Zhang (CR19) 2020; 69
Fu, Sander, Reyon, Cascio, Joung (CR8) 2014; 32
Teng (CR18) 2019; 20
Hsu, Lander, Zhang (CR1) 2014; 157
Tsai (CR4) 2015; 33
Cox (CR20) 2017; 67
Li, Durbin (CR50) 2009; 25
Jinek (CR3) 2012; 337
Chen (CR52) 2020; 178
Soding, Biegert, Lupas (CR37) 2005; 33
Slaymaker (CR9) 2016; 351
Nishimasu (CR26) 2014; 156
Smargon (CR47) 2017; 65
Couvin (CR35) 2018; 46
Chen, Zhou, Chen, Gu (CR48) 2018; 34
Chen (CR16) 2020; 21
You (CR51) 2018; 14
Niu (CR25) 2020; 58
Walton, Hsu, Joung, Kleinstiver (CR24) 2021; 16
Magadan, Dupuis, Villion, Moineau (CR41) 2012; 7
Magoc, Salzberg (CR49) 2011; 27
Burstein (CR23) 2017; 542
Gasiunas (CR40) 2020; 11
Yin (CR11) 2018; 14
Chatterjee, Jakimo, Jacobson (CR42) 2018; 4
Phanstiel, Boyle, Araya, Snyder (CR44) 2014; 30
Tsai, Topkar, Joung, Aryee (CR53) 2016; 34
Hu (CR27) 2015; 125
Landrum (CR31) 2016; 44
Cho (CR10) 2014; 24
Zetsche (CR17) 2015; 163
Katoh, Misawa, Kuma, Miyata (CR39) 2002; 30
Fedorova (CR14) 2020; 48
Kleinstiver (CR7) 2016; 529
Kleinstiver (CR46) 2015; 523
Esvelt (CR22) 2013; 10
Cong (CR2) 2013; 339
Hou (CR12) 2013; 110
Harrington (CR15) 2017; 8
Dobin (CR43) 2013; 29
CR21
Gaudelli (CR30) 2017; 551
Price, Dehal, Arkin (CR38) 2009; 26
Doench (CR6) 2016; 34
Drachkova (CR32) 2014; 35
Savinkova (CR33) 2009; 74
Mali (CR28) 2013; 31
Komor (CR29) 2017; 3
KM Esvelt (29089_CR22) 2013; 10
Z Hu (29089_CR27) 2015; 125
MJ Landrum (29089_CR31) 2016; 44
BP Kleinstiver (29089_CR7) 2016; 529
K Katoh (29089_CR39) 2002; 30
I Drachkova (29089_CR32) 2014; 35
BP Kleinstiver (29089_CR46) 2015; 523
MN Price (29089_CR38) 2009; 26
LK Savinkova (29089_CR33) 2009; 74
SQ Tsai (29089_CR53) 2016; 34
H Yin (29089_CR11) 2018; 14
RT Walton (29089_CR24) 2021; 16
L Cong (29089_CR2) 2013; 339
F Teng (29089_CR18) 2019; 20
B Zetsche (29089_CR17) 2015; 163
A Dobin (29089_CR43) 2013; 29
IM Slaymaker (29089_CR9) 2016; 351
B Zetsche (29089_CR19) 2020; 69
AC Komor (29089_CR29) 2017; 3
JN Zadeh (29089_CR36) 2011; 32
G Niu (29089_CR25) 2020; 58
LB Harrington (29089_CR15) 2017; 8
PD Hsu (29089_CR1) 2014; 157
DH Phanstiel (29089_CR44) 2014; 30
G Gasiunas (29089_CR40) 2020; 11
S Chen (29089_CR48) 2018; 34
SQ Tsai (29089_CR4) 2015; 33
AH Magadan (29089_CR41) 2012; 7
P Mali (29089_CR28) 2013; 31
PD Hsu (29089_CR5) 2013; 31
D Couvin (29089_CR35) 2018; 46
P Chatterjee (29089_CR42) 2018; 4
29089_CR21
AA Smargon (29089_CR47) 2017; 65
M Jinek (29089_CR3) 2012; 337
JG Doench (29089_CR6) 2016; 34
LM Cox (29089_CR20) 2017; 67
J Soding (29089_CR37) 2005; 33
H Li (29089_CR50) 2009; 25
H Nishimasu (29089_CR26) 2014; 156
T Magoc (29089_CR49) 2011; 27
Z Hou (29089_CR12) 2013; 110
I Fedorova (29089_CR14) 2020; 48
Q You (29089_CR51) 2018; 14
NM Gaudelli (29089_CR30) 2017; 551
E Kim (29089_CR13) 2017; 8
Y Chen (29089_CR52) 2020; 178
29089_CR34
DG Gibson (29089_CR45) 2009; 6
SW Cho (29089_CR10) 2014; 24
D Burstein (29089_CR23) 2017; 542
Y Fu (29089_CR8) 2014; 32
P Chen (29089_CR16) 2020; 21
References_xml – volume: 4
  start-page: eaau0766
  year: 2018
  ident: CR42
  article-title: Minimal PAM specificity of a highly similar SpCas9 ortholog
  publication-title: Sci. Adv.
  doi: 10.1126/sciadv.aau0766
– volume: 69
  start-page: 59
  year: 2020
  end-page: 65
  ident: CR19
  article-title: A survey of genome editing activity for 16 Cas12a orthologs
  publication-title: Keio J. Med
  doi: 10.2302/kjm.2019-0009-OA
– volume: 529
  start-page: 490
  year: 2016
  end-page: 495
  ident: CR7
  article-title: High-fidelity CRISPR-Cas9 nucleases with no detectable genome-wide off-target effects
  publication-title: Nature
  doi: 10.1038/nature16526
– volume: 351
  start-page: 84
  year: 2016
  end-page: 88
  ident: CR9
  article-title: Rationally engineered Cas9 nucleases with improved specificity
  publication-title: Science
  doi: 10.1126/science.aad5227
– volume: 31
  start-page: 833
  year: 2013
  end-page: 838
  ident: CR28
  article-title: CAS9 transcriptional activators for target specificity screening and paired nickases for cooperative genome engineering
  publication-title: Nat. Biotechnol.
  doi: 10.1038/nbt.2675
– volume: 337
  start-page: 816
  year: 2012
  end-page: 821
  ident: CR3
  article-title: A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity
  publication-title: Science
  doi: 10.1126/science.1225829
– volume: 10
  start-page: 1116
  year: 2013
  end-page: 1121
  ident: CR22
  article-title: Orthogonal Cas9 proteins for RNA-guided gene regulation and editing
  publication-title: Nat. Methods
  doi: 10.1038/nmeth.2681
– volume: 33
  start-page: W244
  year: 2005
  end-page: W248
  ident: CR37
  article-title: The HHpred interactive server for protein homology detection and structure prediction
  publication-title: Nucleic Acids Res
  doi: 10.1093/nar/gki408
– volume: 20
  year: 2019
  ident: CR18
  article-title: Enhanced mammalian genome editing by new Cas12a orthologs with optimized crRNA scaffolds
  publication-title: Genome Biol.
  doi: 10.1186/s13059-019-1620-8
– ident: CR21
– volume: 163
  start-page: 759
  year: 2015
  end-page: 771
  ident: CR17
  article-title: Cpf1 is a single RNA-guided endonuclease of a class 2 CRISPR-Cas system
  publication-title: Cell
  doi: 10.1016/j.cell.2015.09.038
– volume: 65
  start-page: 618
  year: 2017
  end-page: 630 e617
  ident: CR47
  article-title: Cas13b is a type VI-B CRISPR-associated RNA-guided RNase differentially regulated by accessory proteins Csx27 and Csx28
  publication-title: Mol. Cell
  doi: 10.1016/j.molcel.2016.12.023
– volume: 339
  start-page: 819
  year: 2013
  end-page: 823
  ident: CR2
  article-title: Multiplex genome engineering using CRISPR/Cas systems
  publication-title: Science
  doi: 10.1126/science.1231143
– volume: 8
  year: 2017
  ident: CR15
  article-title: A thermostable Cas9 with increased lifetime in human plasma
  publication-title: Nat. Commun.
  doi: 10.1038/s41467-017-01408-4
– volume: 110
  start-page: 15644
  year: 2013
  end-page: 15649
  ident: CR12
  article-title: Efficient genome engineering in human pluripotent stem cells using Cas9 from Neisseria meningitidis
  publication-title: Proc. Natl Acad. Sci. USA
  doi: 10.1073/pnas.1313587110
– volume: 551
  start-page: 464
  year: 2017
  end-page: 471
  ident: CR30
  article-title: Programmable base editing of A*T to G*C in genomic DNA without DNA cleavage
  publication-title: Nature
  doi: 10.1038/nature24644
– volume: 44
  start-page: D862
  year: 2016
  end-page: D868
  ident: CR31
  article-title: ClinVar: public archive of interpretations of clinically relevant variants
  publication-title: Nucleic Acids Res
  doi: 10.1093/nar/gkv1222
– volume: 46
  start-page: W246
  year: 2018
  end-page: W251
  ident: CR35
  article-title: CRISPRCasFinder, an update of CRISRFinder, includes a portable version, enhanced performance and integrates search for Cas proteins
  publication-title: Nucleic Acids Res
  doi: 10.1093/nar/gky425
– volume: 30
  start-page: 3059
  year: 2002
  end-page: 3066
  ident: CR39
  article-title: MAFFT: a novel method for rapid multiple sequence alignment based on fast Fourier transform
  publication-title: Nucleic Acids Res
  doi: 10.1093/nar/gkf436
– volume: 34
  start-page: i884
  year: 2018
  end-page: i890
  ident: CR48
  article-title: fastp: an ultra-fast all-in-one FASTQ preprocessor
  publication-title: Bioinformatics
  doi: 10.1093/bioinformatics/bty560
– volume: 34
  start-page: 184
  year: 2016
  end-page: 191
  ident: CR6
  article-title: Optimized sgRNA design to maximize activity and minimize off-target effects of CRISPR-Cas9
  publication-title: Nat. Biotechnol.
  doi: 10.1038/nbt.3437
– volume: 48
  start-page: 12297
  year: 2020
  end-page: 12309
  ident: CR14
  article-title: PpCas9 from Pasteurella pneumotropica - a compact Type II-C Cas9 ortholog active in human cells
  publication-title: Nucleic Acids Res
  doi: 10.1093/nar/gkaa998
– volume: 125
  start-page: 425
  year: 2015
  end-page: 436
  ident: CR27
  article-title: TALEN-mediated targeting of HPV oncogenes ameliorates HPV-related cervical malignancy
  publication-title: J. Clin. Invest
  doi: 10.1172/JCI78206
– volume: 16
  start-page: 1511
  year: 2021
  end-page: 1547
  ident: CR24
  article-title: Scalable characterization of the PAM requirements of CRISPR-Cas enzymes using HT-PAMDA
  publication-title: Nat. Protoc.
  doi: 10.1038/s41596-020-00465-2
– volume: 30
  start-page: 2808
  year: 2014
  end-page: 2810
  ident: CR44
  article-title: Sushi.R: flexible, quantitative and integrative genomic visualizations for publication-quality multi-panel figures
  publication-title: Bioinformatics
  doi: 10.1093/bioinformatics/btu379
– volume: 157
  start-page: 1262
  year: 2014
  end-page: 1278
  ident: CR1
  article-title: Development and applications of CRISPR-Cas9 for genome engineering
  publication-title: Cell
  doi: 10.1016/j.cell.2014.05.010
– volume: 33
  start-page: 187
  year: 2015
  end-page: 197
  ident: CR4
  article-title: GUIDE-seq enables genome-wide profiling of off-target cleavage by CRISPR-Cas nucleases
  publication-title: Nat. Biotechnol.
  doi: 10.1038/nbt.3117
– volume: 156
  start-page: 935
  year: 2014
  end-page: 949
  ident: CR26
  article-title: Crystal structure of Cas9 in complex with guide RNA and target DNA
  publication-title: Cell
  doi: 10.1016/j.cell.2014.02.001
– volume: 35
  start-page: 601
  year: 2014
  end-page: 608
  ident: CR32
  article-title: The mechanism by which TATA-box polymorphisms associated with human hereditary diseases influence interactions with the TATA-binding protein
  publication-title: Hum. Mutat.
  doi: 10.1002/humu.22535
– volume: 58
  start-page: 102897
  year: 2020
  ident: CR25
  article-title: An effective vaginal gel to deliver CRISPR/Cas9 system encapsulated in poly (beta-amino ester) nanoparticles for vaginal gene therapy
  publication-title: EBioMedicine
  doi: 10.1016/j.ebiom.2020.102897
– volume: 34
  start-page: 483
  year: 2016
  ident: CR53
  article-title: Open-source guideseq software for analysis of GUIDE-seq data
  publication-title: Nat. Biotechnol.
  doi: 10.1038/nbt.3534
– volume: 523
  start-page: 481
  year: 2015
  end-page: 485
  ident: CR46
  article-title: Engineered CRISPR-Cas9 nucleases with altered PAM specificities
  publication-title: Nature
  doi: 10.1038/nature14592
– volume: 6
  start-page: 343
  year: 2009
  end-page: 345
  ident: CR45
  article-title: Enzymatic assembly of DNA molecules up to several hundred kilobases
  publication-title: Nat. Methods
  doi: 10.1038/nmeth.1318
– volume: 21
  year: 2020
  ident: CR16
  article-title: A Cas12a ortholog with stringent PAM recognition followed by low off-target editing rates for genome editing
  publication-title: Genome Biol.
  doi: 10.1186/s13059-020-01989-2
– volume: 11
  year: 2020
  ident: CR40
  article-title: A catalogue of biochemically diverse CRISPR-Cas9 orthologs
  publication-title: Nat. Commun.
  doi: 10.1038/s41467-020-19344-1
– volume: 3
  start-page: eaao4774
  year: 2017
  ident: CR29
  article-title: Improved base excision repair inhibition and bacteriophage Mu Gam protein yields C:G-to-T:A base editors with higher efficiency and product purity
  publication-title: Sci. Adv.
  doi: 10.1126/sciadv.aao4774
– volume: 74
  start-page: 117
  year: 2009
  end-page: 129
  ident: CR33
  article-title: TATA box polymorphisms in human gene promoters and associated hereditary pathologies
  publication-title: Biochem. (Mosc.)
  doi: 10.1134/S0006297909020011
– volume: 26
  start-page: 1641
  year: 2009
  end-page: 1650
  ident: CR38
  article-title: FastTree: computing large minimum evolution trees with profiles instead of a distance matrix
  publication-title: Mol. Biol. Evol.
  doi: 10.1093/molbev/msp077
– volume: 24
  start-page: 132
  year: 2014
  end-page: 141
  ident: CR10
  article-title: Analysis of off-target effects of CRISPR/Cas-derived RNA-guided endonucleases and nickases
  publication-title: Genome Res
  doi: 10.1101/gr.162339.113
– volume: 14
  start-page: 311
  year: 2018
  end-page: 316
  ident: CR11
  article-title: Partial DNA-guided Cas9 enables genome editing with reduced off-target activity
  publication-title: Nat. Chem. Biol.
  doi: 10.1038/nchembio.2559
– volume: 67
  start-page: 1247
  year: 2017
  end-page: 1254
  ident: CR20
  article-title: Description of two novel members of the family Erysipelotrichaceae: Ileibacterium valens gen. nov., sp. nov. and Dubosiella newyorkensis, gen. nov., sp. nov., from the murine intestine, and emendation to the description of Faecalibaculum rodentium
  publication-title: Int J. Syst. Evol. Microbiol
  doi: 10.1099/ijsem.0.001793
– volume: 7
  start-page: e40913
  year: 2012
  ident: CR41
  article-title: Cleavage of phage DNA by the Streptococcus thermophilus CRISPR3-Cas system
  publication-title: PLoS ONE
  doi: 10.1371/journal.pone.0040913
– volume: 32
  start-page: 170
  year: 2011
  end-page: 173
  ident: CR36
  article-title: NUPACK: Analysis and design of nucleic acid systems
  publication-title: J. Comput Chem.
  doi: 10.1002/jcc.21596
– volume: 178
  start-page: 104794
  year: 2020
  ident: CR52
  article-title: In vitro and in vivo growth inhibition of human cervical cancer cells via human papillomavirus E6/E7 mRNAs’ cleavage by CRISPR/Cas13a system
  publication-title: Antivir. Res
  doi: 10.1016/j.antiviral.2020.104794
– volume: 8
  year: 2017
  ident: CR13
  article-title: In vivo genome editing with a small Cas9 orthologue derived from Campylobacter jejuni
  publication-title: Nat. Commun.
  doi: 10.1038/ncomms14500
– volume: 542
  start-page: 237
  year: 2017
  end-page: 241
  ident: CR23
  article-title: New CRISPR-Cas systems from uncultivated microbes
  publication-title: Nature
  doi: 10.1038/nature21059
– ident: CR34
– volume: 25
  start-page: 1754
  year: 2009
  end-page: 1760
  ident: CR50
  article-title: Fast and accurate short read alignment with Burrows-Wheeler transform
  publication-title: Bioinformatics
  doi: 10.1093/bioinformatics/btp324
– volume: 14
  start-page: 858
  year: 2018
  end-page: 862
  ident: CR51
  article-title: CRISPRMatch: an automatic calculation and visualization tool for high-throughput CRISPR genome-editing data analysis
  publication-title: Int J. Biol. Sci.
  doi: 10.7150/ijbs.24581
– volume: 31
  start-page: 827
  year: 2013
  end-page: 832
  ident: CR5
  article-title: DNA targeting specificity of RNA-guided Cas9 nucleases
  publication-title: Nat. Biotechnol.
  doi: 10.1038/nbt.2647
– volume: 29
  start-page: 15
  year: 2013
  end-page: 21
  ident: CR43
  article-title: STAR: ultrafast universal RNA-seq aligner
  publication-title: Bioinformatics
  doi: 10.1093/bioinformatics/bts635
– volume: 32
  start-page: 279
  year: 2014
  end-page: 284
  ident: CR8
  article-title: Improving CRISPR-Cas nuclease specificity using truncated guide RNAs
  publication-title: Nat. Biotechnol.
  doi: 10.1038/nbt.2808
– volume: 27
  start-page: 2957
  year: 2011
  end-page: 2963
  ident: CR49
  article-title: FLASH: fast length adjustment of short reads to improve genome assemblies
  publication-title: Bioinformatics
  doi: 10.1093/bioinformatics/btr507
– volume: 178
  start-page: 104794
  year: 2020
  ident: 29089_CR52
  publication-title: Antivir. Res
  doi: 10.1016/j.antiviral.2020.104794
– volume: 21
  year: 2020
  ident: 29089_CR16
  publication-title: Genome Biol.
  doi: 10.1186/s13059-020-01989-2
– volume: 30
  start-page: 3059
  year: 2002
  ident: 29089_CR39
  publication-title: Nucleic Acids Res
  doi: 10.1093/nar/gkf436
– volume: 529
  start-page: 490
  year: 2016
  ident: 29089_CR7
  publication-title: Nature
  doi: 10.1038/nature16526
– volume: 46
  start-page: W246
  year: 2018
  ident: 29089_CR35
  publication-title: Nucleic Acids Res
  doi: 10.1093/nar/gky425
– volume: 58
  start-page: 102897
  year: 2020
  ident: 29089_CR25
  publication-title: EBioMedicine
  doi: 10.1016/j.ebiom.2020.102897
– volume: 8
  year: 2017
  ident: 29089_CR15
  publication-title: Nat. Commun.
  doi: 10.1038/s41467-017-01408-4
– volume: 31
  start-page: 833
  year: 2013
  ident: 29089_CR28
  publication-title: Nat. Biotechnol.
  doi: 10.1038/nbt.2675
– volume: 44
  start-page: D862
  year: 2016
  ident: 29089_CR31
  publication-title: Nucleic Acids Res
  doi: 10.1093/nar/gkv1222
– volume: 10
  start-page: 1116
  year: 2013
  ident: 29089_CR22
  publication-title: Nat. Methods
  doi: 10.1038/nmeth.2681
– volume: 163
  start-page: 759
  year: 2015
  ident: 29089_CR17
  publication-title: Cell
  doi: 10.1016/j.cell.2015.09.038
– volume: 35
  start-page: 601
  year: 2014
  ident: 29089_CR32
  publication-title: Hum. Mutat.
  doi: 10.1002/humu.22535
– volume: 16
  start-page: 1511
  year: 2021
  ident: 29089_CR24
  publication-title: Nat. Protoc.
  doi: 10.1038/s41596-020-00465-2
– volume: 8
  year: 2017
  ident: 29089_CR13
  publication-title: Nat. Commun.
  doi: 10.1038/ncomms14500
– ident: 29089_CR34
  doi: 10.1093/database/baz093
– volume: 27
  start-page: 2957
  year: 2011
  ident: 29089_CR49
  publication-title: Bioinformatics
  doi: 10.1093/bioinformatics/btr507
– volume: 48
  start-page: 12297
  year: 2020
  ident: 29089_CR14
  publication-title: Nucleic Acids Res
  doi: 10.1093/nar/gkaa998
– volume: 65
  start-page: 618
  year: 2017
  ident: 29089_CR47
  publication-title: Mol. Cell
  doi: 10.1016/j.molcel.2016.12.023
– volume: 339
  start-page: 819
  year: 2013
  ident: 29089_CR2
  publication-title: Science
  doi: 10.1126/science.1231143
– volume: 32
  start-page: 279
  year: 2014
  ident: 29089_CR8
  publication-title: Nat. Biotechnol.
  doi: 10.1038/nbt.2808
– volume: 34
  start-page: i884
  year: 2018
  ident: 29089_CR48
  publication-title: Bioinformatics
  doi: 10.1093/bioinformatics/bty560
– ident: 29089_CR21
  doi: 10.1101/pdb.prot086785
– volume: 32
  start-page: 170
  year: 2011
  ident: 29089_CR36
  publication-title: J. Comput Chem.
  doi: 10.1002/jcc.21596
– volume: 337
  start-page: 816
  year: 2012
  ident: 29089_CR3
  publication-title: Science
  doi: 10.1126/science.1225829
– volume: 74
  start-page: 117
  year: 2009
  ident: 29089_CR33
  publication-title: Biochem. (Mosc.)
  doi: 10.1134/S0006297909020011
– volume: 6
  start-page: 343
  year: 2009
  ident: 29089_CR45
  publication-title: Nat. Methods
  doi: 10.1038/nmeth.1318
– volume: 67
  start-page: 1247
  year: 2017
  ident: 29089_CR20
  publication-title: Int J. Syst. Evol. Microbiol
  doi: 10.1099/ijsem.0.001793
– volume: 24
  start-page: 132
  year: 2014
  ident: 29089_CR10
  publication-title: Genome Res
  doi: 10.1101/gr.162339.113
– volume: 69
  start-page: 59
  year: 2020
  ident: 29089_CR19
  publication-title: Keio J. Med
  doi: 10.2302/kjm.2019-0009-OA
– volume: 523
  start-page: 481
  year: 2015
  ident: 29089_CR46
  publication-title: Nature
  doi: 10.1038/nature14592
– volume: 110
  start-page: 15644
  year: 2013
  ident: 29089_CR12
  publication-title: Proc. Natl Acad. Sci. USA
  doi: 10.1073/pnas.1313587110
– volume: 156
  start-page: 935
  year: 2014
  ident: 29089_CR26
  publication-title: Cell
  doi: 10.1016/j.cell.2014.02.001
– volume: 20
  year: 2019
  ident: 29089_CR18
  publication-title: Genome Biol.
  doi: 10.1186/s13059-019-1620-8
– volume: 4
  start-page: eaau0766
  year: 2018
  ident: 29089_CR42
  publication-title: Sci. Adv.
  doi: 10.1126/sciadv.aau0766
– volume: 125
  start-page: 425
  year: 2015
  ident: 29089_CR27
  publication-title: J. Clin. Invest
  doi: 10.1172/JCI78206
– volume: 31
  start-page: 827
  year: 2013
  ident: 29089_CR5
  publication-title: Nat. Biotechnol.
  doi: 10.1038/nbt.2647
– volume: 542
  start-page: 237
  year: 2017
  ident: 29089_CR23
  publication-title: Nature
  doi: 10.1038/nature21059
– volume: 29
  start-page: 15
  year: 2013
  ident: 29089_CR43
  publication-title: Bioinformatics
  doi: 10.1093/bioinformatics/bts635
– volume: 7
  start-page: e40913
  year: 2012
  ident: 29089_CR41
  publication-title: PLoS ONE
  doi: 10.1371/journal.pone.0040913
– volume: 30
  start-page: 2808
  year: 2014
  ident: 29089_CR44
  publication-title: Bioinformatics
  doi: 10.1093/bioinformatics/btu379
– volume: 34
  start-page: 184
  year: 2016
  ident: 29089_CR6
  publication-title: Nat. Biotechnol.
  doi: 10.1038/nbt.3437
– volume: 157
  start-page: 1262
  year: 2014
  ident: 29089_CR1
  publication-title: Cell
  doi: 10.1016/j.cell.2014.05.010
– volume: 3
  start-page: eaao4774
  year: 2017
  ident: 29089_CR29
  publication-title: Sci. Adv.
  doi: 10.1126/sciadv.aao4774
– volume: 11
  year: 2020
  ident: 29089_CR40
  publication-title: Nat. Commun.
  doi: 10.1038/s41467-020-19344-1
– volume: 26
  start-page: 1641
  year: 2009
  ident: 29089_CR38
  publication-title: Mol. Biol. Evol.
  doi: 10.1093/molbev/msp077
– volume: 14
  start-page: 858
  year: 2018
  ident: 29089_CR51
  publication-title: Int J. Biol. Sci.
  doi: 10.7150/ijbs.24581
– volume: 34
  start-page: 483
  year: 2016
  ident: 29089_CR53
  publication-title: Nat. Biotechnol.
  doi: 10.1038/nbt.3534
– volume: 14
  start-page: 311
  year: 2018
  ident: 29089_CR11
  publication-title: Nat. Chem. Biol.
  doi: 10.1038/nchembio.2559
– volume: 551
  start-page: 464
  year: 2017
  ident: 29089_CR30
  publication-title: Nature
  doi: 10.1038/nature24644
– volume: 351
  start-page: 84
  year: 2016
  ident: 29089_CR9
  publication-title: Science
  doi: 10.1126/science.aad5227
– volume: 25
  start-page: 1754
  year: 2009
  ident: 29089_CR50
  publication-title: Bioinformatics
  doi: 10.1093/bioinformatics/btp324
– volume: 33
  start-page: W244
  year: 2005
  ident: 29089_CR37
  publication-title: Nucleic Acids Res
  doi: 10.1093/nar/gki408
– volume: 33
  start-page: 187
  year: 2015
  ident: 29089_CR4
  publication-title: Nat. Biotechnol.
  doi: 10.1038/nbt.3117
SSID ssj0000391844
Score 2.5090892
Snippet Genome editing technologies hold tremendous potential in biomedical research and drug development. Therefore, it is imperative to discover gene editing tools...
Gene editing tools have tremendous potential for biomedical and basic research. Here the authors report a Cas9 from Faecalibaculum rodentium (FrCas9) that...
SourceID doaj
pubmedcentral
proquest
pubmed
crossref
springer
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 1425
SubjectTerms 631/1647/1511
631/337/4041/3196
631/61/201/2110
Accuracy
Biotechnology
CRISPR
CRISPR-Associated Protein 9 - genetics
CRISPR-Associated Protein 9 - metabolism
CRISPR-Cas Systems - genetics
Cutting tools
Drug development
Efficiency
Fidelity
Gene Editing - methods
Genetic modification
Genome
Genome editing
Genomes
Humanities and Social Sciences
Medical research
multidisciplinary
RNA, Guide, CRISPR-Cas Systems - genetics
Science
Science (multidisciplinary)
SummonAdditionalLinks – databaseName: Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3Na1QxEA9SKHgR6-eztUTwpo99-U6OunRZPYhUC72FfGJBXqW7PfjfO0nerl21evH2yAcMk0nymzeT3yD00tAstAxw-hmve85k7E00pKcxZeKypsFXts8PcnnG35-L8xulvkpOWKMHboqbCce8jjJwpTOXoswmUXAeAnwlGsrpC3feDWeqnsHMgOvCp1cyA9OzFa9nQklepyXW1eudm6gS9v8JZf6eLPlLxLReRIv76N6EIPGbJvkBupPGB2i_1ZT8_hAtF1dztzL4YoUdnp---_TxdFYbGmczLj9ecSEpxnBtlZxnnCqLRHmCid0YcS7EV4DNH6Gzxcnn-bKfyiX0AWDXugdfMybwrxj3TOgIuM4JE4Py3qSskzfCy4E5F1wmQ_Za6ixENDoNykjPFXuM9sbLMT1F2MioYgqehEC4j8IBjAQkp4ygypNIO0Q2qrNh4hIvJS2-2hrTZto2dVtQt63qtrpDr7ZzvjUmjb-OfltWZDuysGDXBrANO9mG_ZdtdOhos5522porCwgQICUFR6lDL7bdsKlKpMSN6fK6jQHgxtXQoSdt-beSMMFKfIp0SO0Yxo6ouz3jxZdK3A3YsLifHXq9MaGfYt2uimf_QxWH6C4ttl8yEdUR2ltfXafnAKfW_rjunB8Kphke
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: Health & Medical Collection
  dbid: 7X7
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lb9QwEB5BERIX1PIMbZGRuEG0SWzH9gnBitXCAaFCpb1ZfkIllC2b7YF_j8fJploevUWOIzkz4_Fnz_gbgJeqiVy2Lnk_ZWXJaOtL5VVdNj7E2kTZOJvZPj-1y3P2ccVX44FbP6ZV7nxidtR-7fCMfJYW7oQEmoRv31z-LLFqFEZXxxIat-EOUpdhSpdYiemMBdnPJWPjXZmKylnPsmfAFPYGI16l3FuPMm3_v7Dm3ymTf8RN83K0OIT7I44kbwfFH8Gt0D2Au0NlyV8PYbnYzE2vyEVPDJmfffjy-WyWGwbmZoLHrwSpiklavDDzmYTMJYEXMYnpPIlIf5UQ-iM4X7z_Ol-WY9GE0iXwtS3TjtOHtMuizFIufUJ3hivvhLUqRBms4ratqDHOxLqKVrYycu6VDJVQrWWCPoaDbt2Fp0BU64UPztbO1cx6bhKYTHhOKN4IW_umgHonOu1GRnEsbPFD58g2lXoQt07i1lncWhbwavrmcuDTuLH3O9TI1BO5sHPDevNNj1NLc0Ot9K1jQkbWcrSv2nPGnEtPoXEFnOz0qccJ2utrcyrgxfQ6TS2Ml5gurK-GPgm-MVEV8GRQ_zQSyilGqeoCxJ5h7A11_0138T3TdyeEiJvQAl7vTOh6WP8XxbOb_-IY7jVo1ZhpKE7gYLu5CqcJLm3t8zwnfgPYFhAh
  priority: 102
  providerName: ProQuest
– databaseName: Springer Nature OA Free Journals
  dbid: C6C
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1LixQxEC7WFcGL-LZ1lQjetNnuvHPUxmH0ILK6sLeQV-uC9MjM7GH__abSPS2jq-CtSVegqFSSr1KVLwCvDO2FliGvfsbrmjMZaxNNW9OY-tb1mgZf2D4_yeUp_3gmzg6A7u7ClKL9QmlZluldddjxhpcpjbXnFFNVtb4BN5G6Hb26k918roKM55rz6X5Mw_Q1Xff2oELVfx2-_LNM8rdcadmCFnfhzoQdydtR23twkIb7cGt8TfLyASwX685tDDnfEEe6kw9fPp8cl4aRrZngkStBemKSNyysdiap8Efg5Uvihkh6pLzKqPwhnC7ef-2W9fRQQh0y4NrWOcqMKUdWjHsmdMyIzgkTg_LepF4nb4SXDXMuuL5teq-l7oWIRqdGGem5Yo_gcFgN6QkQI6OKKfg2hJb7KFwGkBnDKSOo8m2kFbQ709kwsYjjYxY_bMlmM21Hc9tsblvMbXUFr-c-P0cOjX9Kv8MRmSWR_7o0rNbf7OQPVjjmdZSBK91zKdCn2ig4DyF_JRoqONqNp50m5cZm7JfBJM0hUgUv5995OmGOxA1pdTHKZMjGVVPB43H4Z02YYJiZaitQe46xp-r-n-H8e6HszqgQA88K3uxc6JdafzfF0_8Tfwa3KXo5VhuqIzjcri_S8wyZtv5FmSNXJOMN9Q
  priority: 102
  providerName: Springer Nature
Title FrCas9 is a CRISPR/Cas9 system with high editing efficiency and fidelity
URI https://link.springer.com/article/10.1038/s41467-022-29089-8
https://www.ncbi.nlm.nih.gov/pubmed/35301321
https://www.proquest.com/docview/2640592675
https://www.proquest.com/docview/2640993470
https://pubmed.ncbi.nlm.nih.gov/PMC8931148
https://doaj.org/article/5a3b8d6c478f465f82c1d544cc82ce2c
Volume 13
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3db9MwED_tQ0i8IL4JjMpIvEFYE9ux_YBQV62USkxTR6W-Rf7KmDSl0HYS--85O0lRoSDxkkSOE1nnu9zvcvbvAF6rvOKysPj1U0amjBYuVU5lae58lelK5tZEts-zYjxjkzmf70FX7qgV4GpnaBfqSc2W1-9-fL_9gAb_vtkyLo9XLJp7WJeehzRWKvfhED2TCIb6uYX78ctMFQY0IdGc91mWou-m7T6a3a_Z8lWR0n8XDv1zOeVvOdXoqkb34V6LMcmgUYoHsOfrh3CnqTp5-wjGo-VQrxS5WhFNhtNPF-fT49jQsDqT8GuWBBpjgo4trIomPvJMhE2aRNeOVIEaC9H7Y5iNTr8Mx2lbUCG1CMzWKUajzmMERpmhXDpEfporZ4UxylfSG8VN0adaW11l_crIQlacOyV9X6jCMEGfwEG9qP0zIKpwwnlrMmszZhzXCDQR6wnFc2EylyeQdaIrbcs2HopeXJcx601l2Yi7RHGXUdylTODN5plvDdfGP3ufhBnZ9Aw82bFhsbwsW7MruaZGusIyIStW8KB7meOMWYtXPrcJHHXzWXa6VyJGRNCZYyiVwKvNbTS7kEvRtV_cNH0Q2jHRT-BpM_2bkVBOQwYrS0BsKcbWULfv1FdfI7U3oscQoCbwtlOhX8P6uyie_5fgXsDdPCh5WJQojuBgvbzxLxFZrU0P9sVc4FGOPvbgcDCYXEzwfHJ6dj7F1mEx7MV_Fr1oVj8B7xwfug
linkProvider Scholars Portal
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1LbxMxELZKEYIL4s1CASPBCVbZh722DwhBIEpoqVBppdyMX9tWQpuSpEL9U_xGZry7qcKjt96iXSdyxjPjbzzjbwh5oYqay8qB91NWpqysfKq8ytPChzo3tSycjWyfu9X4gH2a8ukG-dXfhcGyyt4nRkftZw7PyAewcQMSKADfvj35kWLXKMyu9i00WrXYDmc_IWRbvJl8gPV9WRSjj_vDcdp1FUgdoJNlCiGZDxCGlMyWXHqAP4Yr74S1KtQyWMVtlZXGOFPnWW1lJWvOvZIhE6qyTJTwu1fIVdh4M7QoMRWrMx1kW5eMdXdzslIOFix6IiyZLzDDlsq1_S-2CfgXtv27RPOPPG3c_ka3yM0Ot9J3raLdJhuhuUOutZ0sz-6S8Wg-NAtFjxfU0OHe5OuXvUF80DJFUzzupUiNTGGzxEprGiJ3BV78pKbxtEa6LYgI7pGDSxHnfbLZzJrwkFBVeeGDs7lzObOeGwCvgB-F4oWwuS8Skvei065jMMdGGt91zKSXUrfi1iBuHcWtZUJerb5z0vJ3XDj6Pa7IaiRyb8cHs_mh7kxZc1Na6SvHhKxZxVGfc88Zcw4-hcIlZKtfT905hIU-V9-EPF-9BlPG_Ixpwuy0HQNwkYksIQ_a5V_NpOQlZsXyhIg1xVib6vqb5vgo0oUDIsWgNyGvexU6n9b_RfHo4n_xjFwf73_e0TuT3e3H5EaBGo5VjmKLbC7np-EJQLWlfRrtg5Jvl22QvwHZmE1U
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1LbxMxEB6VIhAXxJuFAkaCE6ySXdtr-4AQpEQJRVVVqNSb69dCJbQpSSrUv8avY-zdTRUevfUW7TqRM54Zf-MZfwPwQpU1l5VD76eszBmtfK68KvLSh7owtSydTWyfu9XkgH085Icb8Ku_CxPLKnufmBy1n7l4Rj7AjRuRQIn4dlB3ZRF72-O3Jz_y2EEqZlr7dhqtiuyEs58Yvi3eTLdxrV-W5fjDl9Ek7zoM5A6RyjLH8MwHDEkos5RLj1DIcOWdsFaFWgaruK2G1Bhn6mJYW1nJmnOvZBgKVVkmKP7uFbgqKC-ijYlDsTrficzrkrHuns6QysGCJa8Uy-fLmG3L5dpemFoG_Avn_l2u-UfONm2F41tws8Ow5F2rdLdhIzR34Frb1fLsLkzG85FZKHK8IIaM9qef9_YH6UHLGk3i0S-JNMkEN85YdU1C4rGIl0CJaTypI_UWRgf34OBSxHkfNptZEx4CUZUXPjhbOFcw67lBIItYUiheClv4MoOiF512HZt5bKrxXaesOpW6FbdGceskbi0zeLX6zknL5XHh6PdxRVYjIw93ejCbf9WdWWtuqJW-ckzImlU86nbhOWPO4adQugy2-vXUnXNY6HNVzuD56jWadczVmCbMTtsxCB2ZGGbwoF3-1UwopzFDVmQg1hRjbarrb5rjb4k6HNFpDIAzeN2r0Pm0_i-KRxf_i2dwHU1Rf5ru7jyGG2VU8FjwKLZgczk_DU8QtS3t02QeBI4u2x5_A4o2UYo
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=FrCas9+is+a+CRISPR%2FCas9+system+with+high+editing+efficiency+and+fidelity&rft.jtitle=Nature+communications&rft.au=Cui%2C+Zifeng&rft.au=Tian%2C+Rui&rft.au=Huang%2C+Zhaoyue&rft.au=Jin%2C+Zhuang&rft.date=2022-03-17&rft.issn=2041-1723&rft.eissn=2041-1723&rft.volume=13&rft.issue=1&rft_id=info:doi/10.1038%2Fs41467-022-29089-8&rft.externalDBID=n%2Fa&rft.externalDocID=10_1038_s41467_022_29089_8
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2041-1723&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2041-1723&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2041-1723&client=summon